Post-earnings recap
Reported
Mon, Feb 23, 2026
EPS actual
$-0.56
EPS est.
$-0.70
EPS surprise
+20.34%
1-day move
-4.88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
The earnings report shows that Axsome Therapeutics exceeded expectations on EPS, which is a positive sign for the company. However, the stock fell by 4.88%, likely due to the lack of revenue information and guidance. Investors may be concerned about the company's future performance without clear direction.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.56 | N/A | +20.34% |
| Revenue | N/A | N/A | N/A |
Overall, management expressed a cautious optimism about future developments. They emphasized their commitment to innovation despite market challenges.
Management highlighted ongoing efforts to advance their pipeline.
They acknowledged the challenges in the current market environment.